Further characterization of loss of heterozygosity enhanced by p53 abrogation in human lymphoblastoid TK6 cells: disappearance of endpoint hotspots. 2004

Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
Division of Radioisotope Technology, The Institute of Physical and Chemical Research, Saitama 351-0198, Japan. yatagai@postman.riken.go.jp

Loss of heterozygosity (LOH) is the predominant mechanism of spontaneous mutagenesis at the heterozygous thymindine kinase locus (tk) in TK6 cells. LOH events detected in spontaneous TK(-) mutants (110 clones from p53 wild-type cells TK6-20C and 117 clones from p53-abrogated cells TK6-E6) were analyzed using 13 microsatellite markers spanning the whole of chromosome 17. Our analysis indicated an approximately 60-fold higher frequency of terminal deletions in p53-abrogated cells TK6-E6 compared to p53 wild-type cells TK6-20C whereas frequencies of point mutations (non-LOH events), interstitial deletions, and crossing over events were found to increase only less than twofold by such p53 abrogation. We then made use of an additional 17 microsatellite markers which provided an average map-interval of 1.6Mb to map various LOH endpoints on the 45Mb portion of chromosome 17q corresponding to the maximum length of LOH tracts (i.e. from the distal marker D17S932 to the terminal end). There appeared to be four prominent peaks (I-IV) in the distribution of LOH endpoints/Mb of Tk6-20C cells that were not evident in p53-abrogated cells TK6-E6, where they appeared to be rather broadly distributed along the 15-20Mb length (D17S1807 to D17S1607) surrounding two of the peaks that we detected in TK6-20C cells (peaks II and III). We suggest that the chromosomal instability that is so evident in TK6-E6 cells may be due to DNA double-strand break repair occurring through non homologous end-joining rather than allelic recombination.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002886 Chromosomes, Human, Pair 17 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 17
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations
D019656 Loss of Heterozygosity The loss of one allele at a specific locus, caused by a deletion mutation; or loss of a chromosome from a chromosome pair, resulting in abnormal HEMIZYGOSITY. It is detected when heterozygous markers for a locus appear monomorphic because one of the ALLELES was deleted. Allelic Loss,Heterozygosity, Loss of,Allelic Losses,Heterozygosity Loss

Related Publications

Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
May 2005, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
July 2006, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
January 2005, Environmental and molecular mutagenesis,
Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
December 2007, Mutation research,
Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
June 2021, Toxicology letters,
Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
November 2003, Mutation research,
Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
January 2004, Mutation research,
Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
March 2020, Drug and chemical toxicology,
Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
March 2007, International journal of radiation biology,
Fumio Yatagai, and Shigeko Morimoto, and Takesi Kato, and Masamitsu Honma
December 2013, Mutation research. Genetic toxicology and environmental mutagenesis,
Copied contents to your clipboard!